| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |